chr14-50915373-C-T
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM2PP3_ModeratePP5_Very_Strong
The NM_002863.5(PYGL):c.1366G>A(p.Val456Met) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000242 in 1,614,130 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_002863.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PYGL | ENST00000216392.8 | c.1366G>A | p.Val456Met | missense_variant | Exon 11 of 20 | 1 | NM_002863.5 | ENSP00000216392.7 | ||
PYGL | ENST00000532462.5 | c.1366G>A | p.Val456Met | missense_variant | Exon 11 of 20 | 1 | ENSP00000431657.1 | |||
PYGL | ENST00000544180.6 | c.1264G>A | p.Val422Met | missense_variant | Exon 10 of 19 | 2 | ENSP00000443787.1 | |||
PYGL | ENST00000528757.2 | n.243G>A | non_coding_transcript_exon_variant | Exon 2 of 2 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152118Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000358 AC: 9AN: 251482Hom.: 1 AF XY: 0.0000515 AC XY: 7AN XY: 135918
GnomAD4 exome AF: 0.0000233 AC: 34AN: 1461894Hom.: 1 Cov.: 32 AF XY: 0.0000316 AC XY: 23AN XY: 727248
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152236Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74426
ClinVar
Submissions by phenotype
Glycogen storage disease, type VI Pathogenic:2Other:1
For these reasons, this variant has been classified as Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt PYGL protein function. ClinVar contains an entry for this variant (Variation ID: 21328). This missense change has been observed in individual(s) with glycogen storage disease type VI (PMID: 17705025, 21646031, 32892177). It has also been observed to segregate with disease in related individuals. This variant is present in population databases (rs113993979, gnomAD 0.01%). This sequence change replaces valine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 456 of the PYGL protein (p.Val456Met). -
- -
Variant summary: PYGL c.1366G>A (p.Val456Met) results in a conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 3.6e-05 in 251482 control chromosomes in the gnomAD database, including 1 homozygote. c.1366G>A has been reported in the literature in the compound heterozygous state in multiple individuals affected with clinical features of Glycogen storage disease, type VI (example, Beauchamp_2007, Davit-Spraul_2011, Hoogeveen_2016, Lu_2020), and was found to segregate with disease in 2 siblings. These data indicate that the variant is likely to be associated with disease. At least one publication reports a significant deficiency of PYGL function in compound heterozygous patient cells, however the impact of the p.Val456Met variant alone could not be determined (example, Beauchamp_2007). The following publications have been ascertained in the context of this evaluation (PMID: 17705025, 21646031, 26526422, 32892177). ClinVar contains an entry for this variant (Variation ID: 21328). Based on the evidence outlined above, the variant was classified as likely pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at